Zdrowie i gospodarka · 28/10/2021

Revocation of Authorization of Emergency Use of an In Vitro Diagnostic Device for Detection and/or Diagnosis of COVID-19; Availability

The Food and Drug Administration (FDA) has revoked the Emergency Use Authorization (EUA) for the TaqPath COVID-19 MS2 Combo Kit 2.0, issued to Life Technologies Corporation (a part of Thermo Fisher Scientific, Inc.), due to the Federal Food, Drug, and Cosmetic Act (FD&C Act).